BioLife Sciences Current Assets

BioLife Sciences posts a current assets of $77 as of February 2022. That compares with $140K in the prior-year period — down 99.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioLife Sciences's current assets was $140K. The latest reading is $77 — a 99.9% year-over-year decrease (period ending February 2022). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of BioLife Sciences's financial statement story. At $77, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BLFE's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioLife Sciences's other metric pages and overview cover the third.